• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

MPXV Transmission at a Tattoo Parlor - The New England Journal of Medicine

Mary Wilson

Well-known member
December 14, 2022
DOI: 10.1056/NEJMc2210823


TO THE EDITOR:

From July 6 to 19, 2022, a total of 21 persons were infected by monkeypox (recently renamed mpox) virus (MPXV) that was likely to have been transmitted by means of piercing or tattooing at the same parlor in Cadiz, Spain (Table S1 in the Supplementary Appendix, available with the full text of this letter at NEJM.org). During this period, 21 of 58 customers (36%) at the tattoo parlor became infected (Fig. S1).

Of the 21 infected patients, 14 (67%) were female and 9 (43%) were younger than 18 years of age. The median age of the patients was 26 years (interquartile range, 16 to 38). The patients had no history of recent high-risk sexual activity (e.g., sex without a barrier method of contraception or with multiple partners), travel to areas where mpox is endemic, or close contact with MPXV-infected persons.

Clinical features started with painful regional inflammatory lymphadenopathy, with onset a median of 7 days (interquartile range, 6 to 9) after the piercing or tattooing. All the patients subsequently had local cutaneous inflammation on approximately day 9 (interquartile range, 7 to 11). Physical examination showed cutaneous necrosis in the area of the piercing or tattoo and surrounding umbilicated pustules with an underlying edematous and erythematous plaque (Figure 1). ...

https://www.nejm.org/doi/full/10.1056/NEJMc2210823
 
Back
Top